A prospective randomized double blind cross-over dose-titration study to evaluate the cognitive safety profile of tolterodine as compared to oxybutynin in multiple sclerosis patients with a neurogenic overactive bladder : a planned interim analysis.
Nagels G1, De Deyn P P2, Vleugels L1, D'hooghe M B 1, Van Glabeke I1, Van Laere K1, De Ridder D1 1. Nationaal Multiple Sclerose Centrum, 2. Universiteit Antwerpen
|
|
Abstract 237
|
|
|
Non Discussion Posters:
Scientific Non Discussion Poster Session 19
|
|
|